Prognostic significance of race on biochemical control in patients with localized prostate cancer treated with permanent brachytherapy: Multivariate and matched-pair analyses

International Journal of Radiation Oncology Biology Physics

Volumn 53, Issue 2, 2002, Pages 282-289

  Lee, Lucille N ^a   Barnswell, Carlton ^b   Torre, Taryn ^a   Fearn, Paul ^a   Kattan, Michael ^a   Potters, Louis ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Rockville Centre   (United States)

Author keywords

Brachytherapy; Matched pair analysis; Nomogram; Prostate neoplasm; Race

Indexed keywords

DISEASES; ISOTOPES; PATIENT TREATMENT; RISK ASSESSMENT; TUMORS;

MULTIVARIATE ANALYSES;

RADIOTHERAPY;

ANTIANDROGEN; GONADORELIN; IODINE 125; PALLADIUM 103; PROSTATE SPECIFIC ANTIGEN;

ADJUVANT CHEMOTHERAPY; ARTICLE; BEAM THERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; CONTROLLED STUDY; ETHNOLOGY; FOLLOW UP; GLEASON SCORE; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CARCINOMA; RATING SCALE; STATISTICAL ANALYSIS;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGE FACTORS; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BRACHYTHERAPY; DISEASE-FREE SURVIVAL; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; IODINE RADIOISOTOPES; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PALLADIUM; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOISOTOPES; RADIOTHERAPY DOSAGE; TREATMENT OUTCOME;

EID: 0036603606     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)02747-5     Document Type: Article

References (26)

1. Cancer statistics, 2001
2. Prostate cancer treatment outcome in blacks and whites: A summary of the literature
3. Effect of age and race on the survival of men with prostate cancer in the metropolitan Detroit tricounty area, 1973 to 1987
4. Equivalent racial outcome after conformal radiotherapy for prostate cancer: A single departmental experience
5. Race is not an independent predictor of biochemical recurrence after radical prostatectomy in an equal access medical center
6. Disease recurrence in black and white men undergoing radical prostatectomy for clinical stage T1-T2 prostate cancer
7. The impact of race on freedom from prostate-specific antigen failure in prostate cancer patients treated with definitive radiation therapy
8. Race as an independent predictor of outcome after treatment for localized prostate cancer
9. The impact of race on biochemical disease-free survival in early-stage prostate cancer patients treated with surgery or radiation therapy
10. Prostate cancer in African-American men: Outcome following radiation therapy with or without adjuvant androgen ablation
11. The American Brachytherapy Society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis
12. Some treatment planning considerations for 103Pd and 125I permanent interstitial implants
13. Isotope selection for patients undergoing prostate brachytherapy
14. Consensus statement: Guidelines for PSA following radiation therapy
15. The definition of biochemical failure in patients treated with definitive radiotherapy
16. The National Cancer Data Base report on prostate cancer. American College of Surgeons Commission on Cancer and the American Cancer Society
17. Black-white differences in the stage at presentation of prostate cancer in the District of Columbia
18. Race and cause specific survival with prostate cancer: Influence of clinical stage, Gleason score, age and treatment
19. Race, prostate cancer survival, and membership in a large health maintenance organization
20. Removal of the financial barrier to health care: Does it impact on prostate cancer at presentation and survival? A comparative study between black and white men in a Veterans Affairs system
21. Racial differences in prostate-specific antigen levels in patients with local-regional prostate cancer
22. Prostate-specific antigen levels are higher in African-American than in white patients in a multicenter registration study: Results of RTOG 94-12
23. Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men
24. The National Cancer Data Base report on race, age, and region variations in prostate cancer treatment
25. Treatment of localized prostate cancer in African-American compared with Caucasian men. Less use of aggressive therapy for comparable disease
26. Black versus white racial differences in clinical stage at diagnosis and treatment of prostatic cancer in Connecticut